glp 1 and eye issues Doctor Explains Blindness Risk (Should You Be Worried?) GLP-1 Medications and Your Vision:

Those remain separate questions, distinct from the molecular science described here.

Plus, it builds long-term habits for sustainable success

What explains these groundbreaking results

A greasy T-zone, clogged pores and breakouts

In agreement with expectations, the first outcome trial of a GLP-1RA, the ELIXA trial of the short-acting lixisenatide, an exendin-4 derivative with properties almost identical to those of exendin-4 or exenatide (stable, full agonists of the GLP-1 receptor), showed no increased cardiovascular risk in a patient group with severely increased CVD risk

Kyriakides EC, Filippone N, Paul B, Grattan W, Balint JA